Ausgabe 4/2024
Inhalt (18 Artikel)
Recent developments in marginal zone lymphoma
- Open Access
- short review
Markus Raderer, Barbara Kiesewetter
Escalation of neoadjuvant therapy in triple-negative breast cancer—balancing effectiveness and toxicities
- Open Access
- short review
Christoph Suppan
New therapy options for myelodysplastic syndrome—all for all or targeted?
- Open Access
- short review
Verena Petzer
Treatment sequencing in gastroenteropancreatic neuroendocrine tumors
- Open Access
- short review
Philipp Melhorn, Markus Raderer, Barbara Kiesewetter
Updates and changes in the treatment of cervical cancer
- short review
M. Danisch, M. Postl, T. Bartl, C. Grimm
Impact of the WHO-5 classification of haematolymphoid tumours on clinical practice
- Open Access
- short review
Rosa Brand, Ingrid Simonitsch-Klupp
State-of-the-art therapy and innovative treatment strategies in esophageal squamous cell cancer
- Open Access
- short review
Martin Korpan, Hannah Christina Puhr, Gerald Wolfgang Prager, Aysegül Ilhan-Mutlu
KRAS (Kirsten rat sarcoma) in modern oncology—The molecular pathological point of view
- review
Katja Schmitz, Christoph Schatz, Ludwig Knabl
Importance of genetic clarification in cytopenia syndromes (childhood myelodysplastic syndrome forms)
- Open Access
- case report
Wolfgang Novak, Doris Kroiss, Susanne Karlhuber, Alexandra Frohne, Anna Segarra-Roca, Ingrid Simonitsch-Klupp, Heidrun Boztug, Gernot Engstler, Leo Kager, Kaan Boztug, Michael Dworzak
Can artificial intelligence provide accurate and reliable answers to cancer patients’ questions about cancer pain? Comparison of chatbots based on ESMO cancer pain guideline
- original report
Kadriye Bir Yücel, Osman Sutcuoglu, Ozan Yazıcı, Ahmet Ozet, Nuriye Ozdemir
Alternating chemotherapy with VDC-IE as effective first-line treatment in a patient with SMARCA4-deficient undifferentiated tumor
- Open Access
- case report
Petar Popov, Oskar Steinbrecher, Anke Scharrer, Markus Raderer, Thomas Brodowicz, Matthias Preusser, Wolfgang Lamm
NEC versus NET G3—is there a grey zone? Case report of pancreatic NET G3 with rapid disease progression
- Open Access
- case report
Philipp Melhorn, Markus Raderer, Peter Mazal, Nicolas Kozakowski, Barbara Kiesewetter
GATA2 deficiency: a mystery myelodysplasia
- Open Access
- case report
Raqiya Shoaib, Ashley Pinckney, Ahmed Gawash
